Terms: = Lymphoma AND TFRC, P02786, 7037, ENSG00000072274, TFR1, CD71
154 results:
1. FOXO1 reshapes neutrophils to aggravate acute brain damage and promote late depression after traumatic brain injury.
Zhou M; Liu YW; He YH; Zhang JY; Guo H; Wang H; Ren JK; Su YX; Yang T; Li JB; He WH; Ma PJ; Mi MT; Dai SS
Mil Med Res; 2024 Mar; 11(1):20. PubMed ID: 38556884
[TBL] [Abstract] [Full Text] [Related]
2. Second Treatment-Free Remission Attempt in Patients with Chronic Myeloid Leukemia.
Ureshino H; Kamachi K; Kimura S
Clin Lymphoma Myeloma Leuk; 2024 Apr; 24(4):e138-e141. PubMed ID: 38195325
[TBL] [Abstract] [Full Text] [Related]
3. In Doxorubicin-Adapted Hodgkin lymphoma Cells, Acquiring Multidrug Resistance and Improved Immunosuppressive Abilities, Doxorubicin Activity Was Enhanced by Chloroquine and GW4869.
Casagrande N; Borghese C; Avanzo M; Aldinucci D
Cells; 2023 Nov; 12(23):. PubMed ID: 38067159
[TBL] [Abstract] [Full Text] [Related]
4. Silencing LCN2 enhances RSL3-induced ferroptosis in T cell acute lymphoblastic leukemia.
Tian C; Zheng M; Lan X; Liu L; Ye Z; Li C
Gene; 2023 Aug; 879():147597. PubMed ID: 37390872
[TBL] [Abstract] [Full Text] [Related]
5. Dysregulation of iron homeostasis by TfR-1 renders EZH2 wild type diffuse large B-cell lymphoma resistance to EZH2 inhibition.
Yu L; Wang YF; Xiao J; Shen QQ; Chi SS; Gao YL; Lin DZ; Ding J; Fang YF; Chen Y
Acta Pharmacol Sin; 2023 Oct; 44(10):2113-2124. PubMed ID: 37225847
[TBL] [Abstract] [Full Text] [Related]
6. Reinforcement of cell-mediated immunity driven by tumor-associated Epstein-Barr virus (EBV)-specific T cells during targeted B-cell therapy with rituximab.
Tischer-Zimmermann S; Bonifacius A; Santamorena MM; Mausberg P; Stoll S; Döring M; Kalinke U; Blasczyk R; Maecker-Kolhoff B; Eiz-Vesper B
Front Immunol; 2023; 14():878953. PubMed ID: 37033971
[TBL] [Abstract] [Full Text] [Related]
7. A Systematic Review on Second Treatment-Free Remission (TFR) Attempt in Chronic Myeloid Leukemia (CML): Can it be Applied in Clinical Practice?
Çiftçiler R; Akın MG; Erat Z; Eşkazan AE
Clin Lymphoma Myeloma Leuk; 2023 Jan; 23(1):8-14. PubMed ID: 36344420
[TBL] [Abstract] [Full Text] [Related]
8. A new approach to the study of Hodgkin lymphoma by flow cytometry.
Beatriz Álvarez Flores M; Sopeña Corvinos M; Medrano Élez M; Soto Del Pecho B; Conejo Sánchez L; García de la Fe J; Guillén Santos R; Cava Valenciano F
Pathology; 2023 Feb; 55(1):86-93. PubMed ID: 36137774
[TBL] [Abstract] [Full Text] [Related]
9. Discovery of a Transferrin Receptor 1-Binding Aptamer and Its Application in Cancer Cell Depletion for Adoptive T-Cell Therapy Manufacturing.
Cheng EL; Cardle II; Kacherovsky N; Bansia H; Wang T; Zhou Y; Raman J; Yen A; Gutierrez D; Salipante SJ; des Georges A; Jensen MC; Pun SH
J Am Chem Soc; 2022 Aug; 144(30):13851-13864. PubMed ID: 35875870
[TBL] [Abstract] [Full Text] [Related]
10. Targeting tfr1 with the ch128.1/IgG1 Antibody Inhibits EBV-driven lymphomagenesis in Immunosuppressed Mice Bearing EBV
Martínez LE; Daniels-Wells TR; Guo Y; Magpantay LI; Candelaria PV; Penichet ML; Martínez-Maza O; Epeldegui M
Mol Cancer Ther; 2021 Sep; 20(9):1592-1602. PubMed ID: 34158342
[TBL] [Abstract] [Full Text] [Related]
11. Flow cytometric expression of cd71, CD81, CD44 and CD39 in B cell lymphoma.
Espasa A; Tapia G; Vergara S; Raya M; Juncà J; Sorigue M
Scand J Clin Lab Invest; 2021 Sep; 81(5):413-417. PubMed ID: 34057378
[TBL] [Abstract] [Full Text] [Related]
12. Impact of CD138 Magnetic Bead-based Positive Selection on Bone Marrow Plasma Cell Surface Markers.
Bansal R; Kimlinger T; Gyotoku KA; Smith M; Rajkumar V; Kumar S
Clin Lymphoma Myeloma Leuk; 2021 Jan; 21(1):e48-e51. PubMed ID: 32873534
[TBL] [Abstract] [Full Text] [Related]
13. Transferrin Receptor Is a Specific Ferroptosis Marker.
Feng H; Schorpp K; Jin J; Yozwiak CE; Hoffstrom BG; Decker AM; Rajbhandari P; Stokes ME; Bender HG; Csuka JM; Upadhyayula PS; Canoll P; Uchida K; Soni RK; Hadian K; Stockwell BR
Cell Rep; 2020 Mar; 30(10):3411-3423.e7. PubMed ID: 32160546
[TBL] [Abstract] [Full Text] [Related]
14. Novel lncRNA-IUR suppresses Bcr-Abl-induced tumorigenesis through regulation of STAT5-cd71 pathway.
Wang X; Yang J; Guo G; Feng R; Chen K; Liao Y; Zhang L; Sun L; Huang S; Chen JL
Mol Cancer; 2019 Apr; 18(1):84. PubMed ID: 30961617
[TBL] [Abstract] [Full Text] [Related]
15. A recycling anti-transferrin receptor-1 monoclonal antibody as an efficient therapy for erythroleukemia through target up-regulation and antibody-dependent cytotoxic effector functions.
Neiveyans M; Melhem R; Arnoult C; Bourquard T; Jarlier M; Busson M; Laroche A; Cerutti M; Pugnière M; Ternant D; Gaborit N; Chardès T; Poupon A; Gouilleux-Gruart V; Pèlegrin A; Poul MA
MAbs; 2019 Apr; 11(3):593-605. PubMed ID: 30604643
[TBL] [Abstract] [Full Text] [Related]
16. STAT5 is essential for IL-7-mediated viability, growth, and proliferation of T-cell acute lymphoblastic leukemia cells.
Ribeiro D; Melão A; van Boxtel R; Santos CI; Silva A; Silva MC; Cardoso BA; Coffer PJ; Barata JT
Blood Adv; 2018 Sep; 2(17):2199-2213. PubMed ID: 30185437
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic Value of Transferrin Receptor-1 (cd71) Expression in Acute Lymphoblastic Leukemia.
Hagag AA; Badraia IM; Abdelmageed MM; Hablas NM; Hazzaa SME; Nosair NA
Endocr Metab Immune Disord Drug Targets; 2018; 18(6):610-617. PubMed ID: 29875008
[TBL] [Abstract] [Full Text] [Related]
18. Ibrutinib and idelalisib block immunophenotypic changes associated with the adhesion and activation of CLL cells in the tumor microenvironment.
Shen Y; Best OG; Mulligan SP; Christopherson RI
Leuk Lymphoma; 2018 Aug; 59(8):1927-1937. PubMed ID: 29164976
[TBL] [Abstract] [Full Text] [Related]
19. A rare case of B-lymphoproliferative disorder with villous lymphocytes harboring t(8;14)(q24;q32) translocation.
Shi X; Ba R; You H; Jiang Q; Huang J; Mao J; Han L; Zhang S; Zhuang Q; Yu X; Wang L; Wang Y; Li D; Zhu W; Zhang Y; Zhu Y; Xi X
Front Med; 2018 Jun; 12(3):324-329. PubMed ID: 29075958
[TBL] [Abstract] [Full Text] [Related]
20. Evaluation of primary mediastinal large B cell lymphoma by flow cytometry.
Cherian S; Fromm JR
Cytometry B Clin Cytom; 2018 May; 94(3):459-467. PubMed ID: 28732145
[TBL] [Abstract] [Full Text] [Related]
[Next]
